Astaxanthin in Liver Health and Disease: A Potential Therapeutic Agent

被引：52
|
作者：
Li, Jingjing [1 ]
Guo, Chuanyong [2 ]
Wu, Jianye [1 ]
机构：
[1] Tongji Univ, Putuo Peoples Hosp, Dept Gastroenterol, Sch Med, Shanghai 200060, Peoples R China
[2] Tongji Univ, Shanghai Peoples Hosp 10, Dept Gastroenterol, Sch Med, Shanghai 200072, Peoples R China
来源：
DRUG DESIGN DEVELOPMENT AND THERAPY | 2020年 / 14卷
关键词：
astaxanthin; liver diseases; antioxidants; inflammation; anticancer; HEPATIC STELLATE CELLS; DIET-INDUCED OBESITY; OXIDATIVE STRESS; PPAR-GAMMA; INHIBITS PROLIFERATION; SUBCHRONIC TOXICITY; CAROTENOIDS; APOPTOSIS; INJURY; MICE;
D O I：
10.2147/DDDT.S230749
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Astaxanthin is a carotenoid derived from oxygen-containing non-vitamin A sources and is mainly obtained from marine organisms. Studies have demonstrated that astaxanthin is a natural antioxidant product and it is widely used in the fields of medicine, health-care products and cosmetics. Studies have shown that astaxanthin has important preventive and therapeutic effects on liver fibrosis, non-alcoholic fatty liver, liver cancer, drug and ischemia-induced liver injury, and its mechanism is related to antioxidant and anti-inflammatory activities, and the regulation of multiple signaling pathways. In this review, we discuss the latest data on astaxanthin in the prevention and treatment of liver diseases. An understanding of the structure, source and mechanism of action of astaxanthin in the body would not only provide a theoretical basis for its clinical application but could also have important significance in screening and improving related compounds for the treatment of liver diseases.
引用
收藏
页码：2275 / 2285
页数：11
相关论文
共 50 条
  • [1] Astaxanthin: A Potential Therapeutic Agent in Cardiovascular Disease
    Fassett, Robert G.
    Coombes, Jeff S.
    MARINE DRUGS, 2011, 9 (03) : 447 - 465
  • [2] Astaxanthin: A promising therapeutic agent for organ fibrosis
    Li, Ke
    Wang, Wenhong
    Xiao, Weihua
    PHARMACOLOGICAL RESEARCH, 2023, 188
  • [3] Therapeutic Potential of Astaxanthin in Diabetic Kidney Disease
    Naito, Yuji
    Uchiyama, Kazuhiko
    Handa, Osamu
    Aoi, Wataru
    CAROTENOIDS: BIOSYNTHETIC AND BIOFUNCTIONAL APPROACHES, 2021, 1261 : 239 - 248
  • [4] Astaxanthin as a Potential Neuroprotective Agent for Neurological Diseases
    Wu, Haijian
    Niu, Huanjiang
    Shao, Anwen
    Wu, Cheng
    Dixon, Brandon J.
    Zhang, Jianmin
    Yang, Shuxu
    Wang, Yirong
    MARINE DRUGS, 2015, 13 (09): : 5750 - 5766
  • [5] Astaxanthin Prevents Alcoholic Fatty Liver Disease by Modulating Mouse Gut Microbiota
    Liu, Huilin
    Liu, Meihong
    Fu, Xueqi
    Zhang, Ziqi
    Zhu, Lingyu
    Zheng, Xin
    Liu, Jingsheng
    NUTRIENTS, 2018, 10 (09)
  • [6] Nobiletin from citrus peel: a promising therapeutic agent for liver disease-pharmacological characteristics, mechanisms, and potential applications
    Cheng, Yongkang
    Feng, Sansan
    Sheng, Chuqiao
    Yang, Chunfeng
    Li, Yumei
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [7] Therapeutic potential of astaxanthin and superoxide dismutase in Alzheimer's disease
    Balendra, Vyshnavy
    Singh, Sandeep Kumar
    OPEN BIOLOGY, 2021, 11 (06)
  • [8] Astaxanthin in Cardiovascular Health and Disease
    Fassett, Robert G.
    Coombes, Jeff S.
    MOLECULES, 2012, 17 (02) : 2030 - 2048
  • [9] Astaxanthin targets PI3K/Akt signaling pathway toward potential therapeutic applications
    Zarneshan, Seyede Nazanin
    Fakhri, Sajad
    Farzaei, Mohammad Hosein
    Khan, Haroon
    Saso, Luciano
    FOOD AND CHEMICAL TOXICOLOGY, 2020, 145
  • [10] Peroxisome proliferator-activated receptor α, a potential therapeutic target for alcoholic liver disease
    Nan, Yue-Min
    Wang, Rong-Qi
    Fu, Na
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (25) : 8055 - 8060
12345